From: Untapped ethical resources for neurodegeneration research
Age | N (%) | Research Area | N (%) |
---|---|---|---|
<30 | 12 (6%) | Drug discovery | 97 (50%) |
31-50 | 108 (56%) | Other (e.g., basic research) | 80 (41%) |
51+ | 65 (34%) | Regenerative medicine | 48 (25%) |
Gender | Â | Research Focus | Â |
Male | 119 (62%) | Other (e.g., cell culture) | 161 (83%) |
Female | 70 (36%) | Other animals | 134 (69%) |
Professional Level | Â | Non-human primates | 74 (38%) |
Faculty | 154 (80%) | Adults with ND disease | 64 (33%) |
Graduate or Medical Student | 17 (9%) | Healthy adults | 37 (19%) |
Post-doctoral Fellow | 10 (5%) | Disease Focus | Â |
Research Staff | 5 (3%) | Alzheimer's | 98 (51%) |
Highest Degree Attained | Â | Other | 71 (37%) |
PhD and/or MD | 174 (90%) | Parkinson's | 51 (26%) |
BA, BS or equivalent | 10 (5%) | Huntington's | 38 (20%) |
MA, MS or equivalent | 7 (4%) | ALS | 32 (17%) |
Head of Research Group | Â | MS | 13 (7%) |
Yes | 158 (82%) | Â | Â |
No | 33 (17%) | Â | Â |